Global Guaifenesin API Powder Market Research Report 2024

Publication ID:

PB506244961

Publication Date:

June 6, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Guaifenesin API Powder is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
The global Guaifenesin API Powder market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Guaifenesin API Powder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Guaifenesin API Powder.
Report Scope
The Guaifenesin API Powder market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Guaifenesin API Powder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Guaifenesin API Powder manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Granules
Synthokem Labs
Haizhou Pharma
Yuan Cheng Group
Stellar Chemical
Seven Star Pharma
Gennex Lab
Iwaki Seiyaku
Pan Drugs
Delta Synthetic
Smart Pharm
Segment by Type
>99%
98%-99%
Segment by Application
Pharmaceuticals
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Guaifenesin API Powder manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Guaifenesin API Powder by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Guaifenesin API Powder in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Guaifenesin API Powder Market Overview
1.1 Product Definition
1.2 Guaifenesin API Powder Segment by Type
1.2.1 Global Guaifenesin API Powder Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 >99%
1.2.3 98%-99%
1.3 Guaifenesin API Powder Segment by Application
1.3.1 Global Guaifenesin API Powder Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Pharmaceuticals
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Guaifenesin API Powder Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Guaifenesin API Powder Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Guaifenesin API Powder Production Estimates and Forecasts (2019-2030)
1.4.4 Global Guaifenesin API Powder Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Guaifenesin API Powder Production Market Share by Manufacturers (2019-2024)
2.2 Global Guaifenesin API Powder Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Guaifenesin API Powder, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Guaifenesin API Powder Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Guaifenesin API Powder Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Guaifenesin API Powder, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Guaifenesin API Powder, Product Offered and Application
2.8 Global Key Manufacturers of Guaifenesin API Powder, Date of Enter into This Industry
2.9 Guaifenesin API Powder Market Competitive Situation and Trends
2.9.1 Guaifenesin API Powder Market Concentration Rate
2.9.2 Global 5 and 10 Largest Guaifenesin API Powder Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Guaifenesin API Powder Production by Region
3.1 Global Guaifenesin API Powder Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Guaifenesin API Powder Production Value by Region (2019-2030)
3.2.1 Global Guaifenesin API Powder Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Guaifenesin API Powder by Region (2025-2030)
3.3 Global Guaifenesin API Powder Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Guaifenesin API Powder Production by Region (2019-2030)
3.4.1 Global Guaifenesin API Powder Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Guaifenesin API Powder by Region (2025-2030)
3.5 Global Guaifenesin API Powder Market Price Analysis by Region (2019-2024)
3.6 Global Guaifenesin API Powder Production and Value, Year-over-Year Growth
3.6.1 North America Guaifenesin API Powder Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Guaifenesin API Powder Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Guaifenesin API Powder Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Guaifenesin API Powder Production Value Estimates and Forecasts (2019-2030)
4 Guaifenesin API Powder Consumption by Region
4.1 Global Guaifenesin API Powder Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Guaifenesin API Powder Consumption by Region (2019-2030)
4.2.1 Global Guaifenesin API Powder Consumption by Region (2019-2024)
4.2.2 Global Guaifenesin API Powder Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Guaifenesin API Powder Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Guaifenesin API Powder Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Guaifenesin API Powder Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Guaifenesin API Powder Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Guaifenesin API Powder Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Guaifenesin API Powder Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Guaifenesin API Powder Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Guaifenesin API Powder Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Guaifenesin API Powder Production by Type (2019-2030)
5.1.1 Global Guaifenesin API Powder Production by Type (2019-2024)
5.1.2 Global Guaifenesin API Powder Production by Type (2025-2030)
5.1.3 Global Guaifenesin API Powder Production Market Share by Type (2019-2030)
5.2 Global Guaifenesin API Powder Production Value by Type (2019-2030)
5.2.1 Global Guaifenesin API Powder Production Value by Type (2019-2024)
5.2.2 Global Guaifenesin API Powder Production Value by Type (2025-2030)
5.2.3 Global Guaifenesin API Powder Production Value Market Share by Type (2019-2030)
5.3 Global Guaifenesin API Powder Price by Type (2019-2030)
6 Segment by Application
6.1 Global Guaifenesin API Powder Production by Application (2019-2030)
6.1.1 Global Guaifenesin API Powder Production by Application (2019-2024)
6.1.2 Global Guaifenesin API Powder Production by Application (2025-2030)
6.1.3 Global Guaifenesin API Powder Production Market Share by Application (2019-2030)
6.2 Global Guaifenesin API Powder Production Value by Application (2019-2030)
6.2.1 Global Guaifenesin API Powder Production Value by Application (2019-2024)
6.2.2 Global Guaifenesin API Powder Production Value by Application (2025-2030)
6.2.3 Global Guaifenesin API Powder Production Value Market Share by Application (2019-2030)
6.3 Global Guaifenesin API Powder Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Granules
7.1.1 Granules Guaifenesin API Powder Corporation Information
7.1.2 Granules Guaifenesin API Powder Product Portfolio
7.1.3 Granules Guaifenesin API Powder Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Granules Main Business and Markets Served
7.1.5 Granules Recent Developments/Updates
7.2 Synthokem Labs
7.2.1 Synthokem Labs Guaifenesin API Powder Corporation Information
7.2.2 Synthokem Labs Guaifenesin API Powder Product Portfolio
7.2.3 Synthokem Labs Guaifenesin API Powder Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Synthokem Labs Main Business and Markets Served
7.2.5 Synthokem Labs Recent Developments/Updates
7.3 Haizhou Pharma
7.3.1 Haizhou Pharma Guaifenesin API Powder Corporation Information
7.3.2 Haizhou Pharma Guaifenesin API Powder Product Portfolio
7.3.3 Haizhou Pharma Guaifenesin API Powder Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Haizhou Pharma Main Business and Markets Served
7.3.5 Haizhou Pharma Recent Developments/Updates
7.4 Yuan Cheng Group
7.4.1 Yuan Cheng Group Guaifenesin API Powder Corporation Information
7.4.2 Yuan Cheng Group Guaifenesin API Powder Product Portfolio
7.4.3 Yuan Cheng Group Guaifenesin API Powder Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Yuan Cheng Group Main Business and Markets Served
7.4.5 Yuan Cheng Group Recent Developments/Updates
7.5 Stellar Chemical
7.5.1 Stellar Chemical Guaifenesin API Powder Corporation Information
7.5.2 Stellar Chemical Guaifenesin API Powder Product Portfolio
7.5.3 Stellar Chemical Guaifenesin API Powder Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Stellar Chemical Main Business and Markets Served
7.5.5 Stellar Chemical Recent Developments/Updates
7.6 Seven Star Pharma
7.6.1 Seven Star Pharma Guaifenesin API Powder Corporation Information
7.6.2 Seven Star Pharma Guaifenesin API Powder Product Portfolio
7.6.3 Seven Star Pharma Guaifenesin API Powder Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Seven Star Pharma Main Business and Markets Served
7.6.5 Seven Star Pharma Recent Developments/Updates
7.7 Gennex Lab
7.7.1 Gennex Lab Guaifenesin API Powder Corporation Information
7.7.2 Gennex Lab Guaifenesin API Powder Product Portfolio
7.7.3 Gennex Lab Guaifenesin API Powder Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Gennex Lab Main Business and Markets Served
7.7.5 Gennex Lab Recent Developments/Updates
7.8 Iwaki Seiyaku
7.8.1 Iwaki Seiyaku Guaifenesin API Powder Corporation Information
7.8.2 Iwaki Seiyaku Guaifenesin API Powder Product Portfolio
7.8.3 Iwaki Seiyaku Guaifenesin API Powder Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Iwaki Seiyaku Main Business and Markets Served
7.7.5 Iwaki Seiyaku Recent Developments/Updates
7.9 Pan Drugs
7.9.1 Pan Drugs Guaifenesin API Powder Corporation Information
7.9.2 Pan Drugs Guaifenesin API Powder Product Portfolio
7.9.3 Pan Drugs Guaifenesin API Powder Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Pan Drugs Main Business and Markets Served
7.9.5 Pan Drugs Recent Developments/Updates
7.10 Delta Synthetic
7.10.1 Delta Synthetic Guaifenesin API Powder Corporation Information
7.10.2 Delta Synthetic Guaifenesin API Powder Product Portfolio
7.10.3 Delta Synthetic Guaifenesin API Powder Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Delta Synthetic Main Business and Markets Served
7.10.5 Delta Synthetic Recent Developments/Updates
7.11 Smart Pharm
7.11.1 Smart Pharm Guaifenesin API Powder Corporation Information
7.11.2 Smart Pharm Guaifenesin API Powder Product Portfolio
7.11.3 Smart Pharm Guaifenesin API Powder Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Smart Pharm Main Business and Markets Served
7.11.5 Smart Pharm Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Guaifenesin API Powder Industry Chain Analysis
8.2 Guaifenesin API Powder Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Guaifenesin API Powder Production Mode & Process
8.4 Guaifenesin API Powder Sales and Marketing
8.4.1 Guaifenesin API Powder Sales Channels
8.4.2 Guaifenesin API Powder Distributors
8.5 Guaifenesin API Powder Customers
9 Guaifenesin API Powder Market Dynamics
9.1 Guaifenesin API Powder Industry Trends
9.2 Guaifenesin API Powder Market Drivers
9.3 Guaifenesin API Powder Market Challenges
9.4 Guaifenesin API Powder Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Granules
Synthokem Labs
Haizhou Pharma
Yuan Cheng Group
Stellar Chemical
Seven Star Pharma
Gennex Lab
Iwaki Seiyaku
Pan Drugs
Delta Synthetic
Smart Pharm

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂